Aveanna Healthcare Holdings Inc. Common Stock
Here’s whether Aveanna Healthcare Holdings Inc. Common Stock (AVAH) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+11.11% over 10 days); strong 1-year return of +86.9%; 3-month momentum positive (+79.5%); rising volume confirms the move (1.71x 30d avg). Concerns: RSI 81 — overbought, elevated pullback risk. Currently 3.3% off its 52-week high. Score: +6/7.
AVAH is in a confirmed uptrend, trading above both its 50-day ($9.52) and 200-day ($8.18) moving averages. With an RSI of 81.4, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +86.9% compares to +20.5% for SPY (beat the market by 66.5%).